Cergutuzumab amunaleukin, CAS 1509916-03-3

Product Description: Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Christian Klein, et al. Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines. Oncoimmunology. 2017 Jan 11;6(3):e1277306.

CAS Number: 1509916-03-3

Molecular Weight: N/A

Compound Purity: 99.5

Research Area: Cancer; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99498-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99498-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated